5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.02▲ | 0.96▲ | 0.96▲ | 0.96▲ | 0.98▲ |
MA10 | 0.96▲ | 0.92▲ | 0.93▲ | 0.95▲ | 1.11▼ |
MA20 | 0.92▲ | 0.92▲ | 0.94▲ | 0.96▲ | 1.31▼ |
MA50 | 0.94▲ | 0.96▲ | 0.97▲ | 1.14▼ | 1.34▼ |
MA100 | 0.97▲ | 1.05▲ | 1.09▼ | 1.34▼ | 2.22▼ |
MA200 | 1.07▼ | 1.15▼ | 1.19▼ | 1.31▼ | 4.72▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.018▲ | 0.018▲ | 0.017▲ | 0.020▲ | -0.040▼ |
RSI | 68.325▲ | 67.252▲ | 63.777▲ | 52.926▲ | 43.309▼ |
STOCH | 87.533▲ | 87.355▲ | 67.498 | 45.233 | 33.882 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -16.706▲ | -61.380 |
CCI | 138.690▲ | 231.800▲ | 181.560▲ | 122.874▲ | -73.526 |
Thursday, May 01, 2025 06:00 AM
Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion® today ...
|
Tuesday, April 29, 2025 04:14 PM
CLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a ...
|
Tuesday, April 29, 2025 05:13 AM
April 29, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (“Apyx Medical” or the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.01 | 1.09 | 0.9702 | 1.07 | 45,491 |
30/04/25 | 0.91 | 1.0949 | 0.90 | 1.04 | 63,950 |
29/04/25 | 0.90 | 0.9376 | 0.8743 | 0.91 | 65,215 |
28/04/25 | 0.935 | 0.94 | 0.8863 | 0.90 | 26,718 |
25/04/25 | 0.9113 | 0.9263 | 0.8252 | 0.8905 | 35,756 |
24/04/25 | 0.95 | 0.99 | 0.8901 | 0.9096 | 126,872 |
23/04/25 | 0.95 | 0.991 | 0.8999 | 0.8999 | 67,775 |
22/04/25 | 1.00 | 1.02 | 0.892 | 0.9425 | 90,603 |
21/04/25 | 0.94 | 1.01 | 0.9116 | 0.98 | 43,607 |
17/04/25 | 0.93 | 1.00 | 0.93 | 0.975 | 93,253 |
|
|
||||
|
|
||||
|
|